Moran Kyle

Chief Financial OfficerWave Life Sciences Ltd. (WVE) · full profile →Form 4 · filed Dec 10, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$4.1M
Net Open-Market Flow
-$4.1M
Transactions
16
11 non-derivative · 5 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 9, 2025Sell(S)36$20.25$72989K
Dec 9, 2025Option exercise(M)36K$8.17$294K125K
Dec 9, 2025Sell(S)50K$20.03$1.0M90K
Dec 9, 2025Option exercise(M)50K$10.48$524K139K
Dec 8, 2025Sell(S)50K$15.00$750K139K
Dec 8, 2025Option exercise(M)100K$3.14$314K189K
Dec 8, 2025Sell(S)50K$18.00$900K89K
Dec 8, 2025Option exercise(M)60K$2.83$170K149K
Dec 8, 2025Sell(S)60K$13.20$792K89K
Dec 8, 2025Option exercise(M)50K$4.75$238K139K
Dec 8, 2025Sell(S)50K$13.20$660K89K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Dec 9, 2025Grant(A)36K$00
Dec 9, 2025Grant(A)50K$00
Dec 8, 2025Grant(A)60K$00
Dec 8, 2025Grant(A)100K$075K
Dec 8, 2025Grant(A)50K$0223K

Transaction Codes

S
Open-market sale
M
Option exercise / conversion
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001193125-25-314736) within minutes of acceptance. Every field above traces to the original document. Verify it directly: